Pure Global

The Oslo Acute Reperfusion Stroke Study (OSCAR) - Trial NCT06220981

Access comprehensive clinical trial information for NCT06220981 through Pure Global AI's free database. This phase not specified trial is sponsored by Oslo University Hospital and is currently Recruiting. The study focuses on Acute Ischemic Stroke. Target enrollment is 1500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06220981
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06220981
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Oslo Acute Reperfusion Stroke Study (OSCAR)

Study Focus

Acute Ischemic Stroke

Endovascular treatment

Observational

other

Sponsor & Location

Oslo University Hospital

Oslo, Norway

Timeline & Enrollment

N/A

Jan 10, 2017

Dec 31, 2025

1500 participants

Primary Outcome

Modified Rankin Scale Score

Summary

Prospective registry of clinical and radiological data in acute ischemic stroke patients
 after endovascular treatment.

ICD-10 Classifications

Stroke, not specified as haemorrhage or infarction
Sequelae of stroke, not specified as haemorrhage or infarction
Cerebral infarction
Cerebral infarction, unspecified
Transient cerebral ischaemic attack, unspecified

Data Source

ClinicalTrials.gov

NCT06220981

Non-Device Trial